Roivant Sciences Ltd (NASDAQ: ROIV) kicked off on Monday, up 3.35% from the previous trading day, before settling in for the closing price of $9.86. Over the past 52 weeks, ROIV has traded in a range of $8.73-$13.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 29.37% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded -105.88%. With a float of $438.67 million, this company’s outstanding shares have now reached $719.63 million.
In an organization with 908 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 89.03%, operating margin of -1027.4%, and the pretax margin is -594.75%.
Roivant Sciences Ltd (ROIV) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Roivant Sciences Ltd is 38.52%, while institutional ownership is 68.69%. The most recent insider transaction that took place on Mar 24 ’25, was worth 4,701,052. In this transaction President & COO of this company sold 434,478 shares at a rate of $10.82, taking the stock ownership to the 1,127,290 shares. Before that another transaction happened on Mar 20 ’25, when Company’s President & COO sold 315,522 for $11.06, making the entire transaction worth $3,489,673. This insider now owns 959,457 shares in total.
Roivant Sciences Ltd (ROIV) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.25 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -105.88% per share during the next fiscal year.
Roivant Sciences Ltd (NASDAQ: ROIV) Trading Performance Indicators
Take a look at Roivant Sciences Ltd’s (ROIV) current performance indicators. Last quarter, stock had a quick ratio of 37.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 74.53.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.14, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -1.12 in one year’s time.
Technical Analysis of Roivant Sciences Ltd (ROIV)
Let’s dig in a bit further. During the last 5-days, its volume was 7.85 million. That was better than the volume of 5.86 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 79.01%. Additionally, its Average True Range was 0.48.
During the past 100 days, Roivant Sciences Ltd’s (ROIV) raw stochastic average was set at 34.72%, which indicates a significant decrease from 74.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.43% in the past 14 days, which was higher than the 35.09% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.44, while its 200-day Moving Average is $11.26. However, in the short run, Roivant Sciences Ltd’s stock first resistance to watch stands at $10.34. Second resistance stands at $10.50. The third major resistance level sits at $10.73. If the price goes on to break the first support level at $9.95, it is likely to go to the next support level at $9.72. Assuming the price breaks the second support level, the third support level stands at $9.56.
Roivant Sciences Ltd (NASDAQ: ROIV) Key Stats
The company with the Market Capitalisation of 7.27 billion has total of 713,549K Shares Outstanding. Its annual sales at the moment are 124,800 K in contrast with the sum of 4,349 M annual income. Company’s last quarter sales were recorded 9,020 K and last quarter income was 169,380 K.
